BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25070850)

  • 1. Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin.
    Nasr N; Lai J; Botting RA; Mercier SK; Harman AN; Kim M; Turville S; Center RJ; Domagala T; Gorry PR; Olbourne N; Cunningham AL
    J Immunol; 2014 Sep; 193(5):2554-64. PubMed ID: 25070850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.
    van der Vlist M; de Witte L; de Vries RD; Litjens M; de Jong MA; Fluitsma D; de Swart RL; Geijtenbeek TB
    Eur J Immunol; 2011 Sep; 41(9):2619-31. PubMed ID: 21739428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function.
    de Jong MA; de Witte L; Taylor ME; Geijtenbeek TB
    J Immunol; 2010 Aug; 185(3):1633-41. PubMed ID: 20592277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors.
    de Jong MA; de Witte L; Santegoets SJ; Fluitsma D; Taylor ME; de Gruijl TD; Geijtenbeek TB
    J Leukoc Biol; 2010 Apr; 87(4):637-43. PubMed ID: 20042470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
    van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB
    J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.
    de Witte L; Nabatov A; Pion M; Fluitsma D; de Jong MA; de Gruijl T; Piguet V; van Kooyk Y; Geijtenbeek TB
    Nat Med; 2007 Mar; 13(3):367-71. PubMed ID: 17334373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 mediated uptake via langerin restricts HIV-1 infection in human Langerhans cells.
    van den Berg LM; Ribeiro CM; Zijlstra-Willems EM; de Witte L; Fluitsma D; Tigchelaar W; Everts V; Geijtenbeek TB
    Retrovirology; 2014 Dec; 11():123. PubMed ID: 25551286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Herpesvirus 8 Infects and Replicates in Langerhans Cells and Interstitial Dermal Dendritic Cells and Impairs Their Function.
    Rappocciolo G; Jais M; Piazza PA; DeLucia DC; Jenkins FJ; Rinaldo CR
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
    Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting human langerin promotes HIV-1 specific humoral immune responses.
    Kervevan J; Bouteau A; Lanza JS; Hammoudi A; Zurawski S; Surenaud M; Dieudonné L; Bonnet M; Lefebvre C; Hocini H; Marlin R; Guguin A; Hersant B; Hermeziu O; Menu E; Lacabaratz C; Lelièvre JD; Zurawski G; Godot V; Henri S; Igyártó BZ; Levy Y; Cardinaud S
    PLoS Pathog; 2021 Jul; 17(7):e1009749. PubMed ID: 34324611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets.
    Ribeiro CM; Sarrami-Forooshani R; Setiawan LC; Zijlstra-Willems EM; van Hamme JL; Tigchelaar W; van der Wel NN; Kootstra NA; Gringhuis SI; Geijtenbeek TB
    Nature; 2016 Dec; 540(7633):448-452. PubMed ID: 27919079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndecan 4 Upregulation on Activated Langerhans Cells Counteracts Langerin Restriction to Facilitate Hepatitis C Virus Transmission.
    Nijmeijer BM; Eder J; Langedijk CJM; Kaptein TM; Meeussen S; Zimmermann P; Ribeiro CMS; Geijtenbeek TBH
    Front Immunol; 2020; 11():503. PubMed ID: 32292405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site.
    Chatwell L; Holla A; Kaufer BB; Skerra A
    Mol Immunol; 2008 Apr; 45(7):1981-94. PubMed ID: 18061677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerin functions as an antiviral receptor on Langerhans cells.
    van der Vlist M; Geijtenbeek TB
    Immunol Cell Biol; 2010; 88(4):410-5. PubMed ID: 20309013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
    Holla A; Skerra A
    Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin gene-related peptide inhibits Langerhans cell-mediated HIV-1 transmission.
    Ganor Y; Drillet-Dangeard AS; Lopalco L; Tudor D; Tambussi G; Delongchamps NB; Zerbib M; Bomsel M
    J Exp Med; 2013 Oct; 210(11):2161-70. PubMed ID: 24081951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural studies of langerin and Birbeck granule: a macromolecular organization model.
    Thépaut M; Valladeau J; Nurisso A; Kahn R; Arnou B; Vivès C; Saeland S; Ebel C; Monnier C; Dezutter-Dambuyant C; Imberty A; Fieschi F
    Biochemistry; 2009 Mar; 48(12):2684-98. PubMed ID: 19175323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acutely infected Langerhans cells are more efficient than T cells in disseminating HIV type 1 to activated T cells following a short cell-cell contact.
    Ayehunie S; Groves RW; Bruzzese AM; Ruprecht RM; Kupper TS; Langhoff E
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):877-84. PubMed ID: 7492434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission.
    de Witte L; Nabatov A; Geijtenbeek TB
    Trends Mol Med; 2008 Jan; 14(1):12-9. PubMed ID: 18055263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors.
    Stoitzner P; Schaffenrath S; Tripp CH; Reider D; Komenda K; Del Frari B; Djedovic G; Ebner S; Romani N
    Exp Dermatol; 2014 Dec; 23(12):909-15. PubMed ID: 25346475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.